Researching Emotions And Cardiac Health: Phase III

Description

The focus of this study is to examine the feasibility, acceptability, and preliminary impact of a 12-week, telephone-delivered, positive psychology (PP)-based health behavior intervention in a group of patients with mild to moderate heart failure (HF), compared to a motivational interviewing- (MI-) based education condition and treatment as usual (TAU).

Study Start Date

September, 01 2017

Estimated Completion Date

November 2019

Interventions

  • Behavioral: MI-based educational control condition
  • Behavioral: PP-based health behavior intervention

Study ID

Massachusetts General Hospital -- 5K23HL123607-03

Status

Recruiting

Trial ID

NCT03220204

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

75

Sponsor

Massachusetts General Hospital

Inclusion Criteria

  • Adult patients with NYHA class I, II, or III HF admitted to an MGH inpatient unit or outpatients at the MGH Heart Center or MGH-affiliated primary care clinic. Patients with NYHA class IV HF have ongoing HF symptoms at rest, making it difficult for them to increase physical activity and other health behaviors
  • therefore, they will not be included. HF diagnosis will be confirmed via chart review and with the patient's treatment team as needed.
  • Suboptimal adherence to health behaviors. This will be defined as a total score of ?15 on three Medical Outcomes Study Specific Adherence Scale (MOS) items regarding diet/exercise/medications. The MOS has been used in multiple prior studies assessing adherence in cardiac patients, including our own studies in this population. This threshold score on the MOS will ensure that all participants will have the potential to improve their health behaviors.

Exclusion Criteria

  • Cognitive deficits impeding a participant's ability to provide informed consent or participate, assessed via a 6-item cognitive test that is sensitive and specific for screening for cognitive impairment in research participants.
  • Medical conditions precluding interviews or likely to lead to death within 6 months.
  • Inability to speak English, inability to read or write, inability to walk, or lack of a telephone.

Gender

All

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (6)

Study Location Distance Name Phone Email
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Christopher Celano MD 617-726-6485 ccelano@mgh.harvard.edu
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Christopher Celano MD 617-726-6485 ccelano@mgh.harvard.edu
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Christopher Celano MD 617-726-6485 ccelano@mgh.harvard.edu
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Christopher Celano MD 617-726-6485 ccelano@mgh.harvard.edu
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Christopher Celano MD 617-726-6485 ccelano@mgh.harvard.edu
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Christopher Celano MD 617-726-6485 ccelano@mgh.harvard.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.